Canada seeks U.S. help to solve EpiPen shortage

TORONTO (Reuters) – Canada said on Tuesday it is working with the U.S. Food and Drug Administration to access supplies of Mylan N.V.’s EpiPen emergency allergy antidote amid a growing shortage that has spared the United States.


Source: Reuters Medical News

Type 2 diabetes drugs vary in impact on survival

Overall mortality lower with SGLT-2 inhibitors and GLP-1 agonists than with DPP-4 inhibitors

Related items from OnMedica

Use of DPP-4 inhibitors associated with increased risk of IBD
Drugs to treat diabetes are well tolerated in teenagers
Intensive weight loss can ‘reverse’ type 2 diabetes
NHS type 2 Diabetes Prevention Programme exceeds expectations
Study claims medical treatment can reverse type 2 diabetes


Source: OnMedica